Last reviewed · How we verify
Neuropathic pain associated with diabetic peripheral neuropathy
Approved treatments
- Lyrica · Pfizer Inc.
Pregabalin binds alpha-2-delta subunit of voltage-gated calcium channels in CNS.
Clinical guidelines
- FDA label — 1L
Pregabalin capsules are indicated for the management of neuropathic pain associated with diabetic peripheral neuropathy. - FDA label — 1L
Pregabalin capsules are indicated for the management of postherpetic neuralgia. - FDA label — 1L
Pregabalin capsules are indicated for the management of fibromyalgia. - FDA label — 1L
Pregabalin capsules are indicated for the management of neuropathic pain associated with spinal cord injury.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Neuropathic pain associated with diabetic peripheral neuropathy patent landscape — cliff calendar, originator estates, attackable patents
- Neuropathic pain associated with diabetic peripheral neuropathy treatment landscape brief
- Neuropathic pain associated with diabetic peripheral neuropathy treatment updates RSS
Frequently asked questions about Neuropathic pain associated with diabetic peripheral neuropathy
What drugs treat Neuropathic pain associated with diabetic peripheral neuropathy?
Tracked treatments include Lyrica.
What is the treatment for Neuropathic pain associated with diabetic peripheral neuropathy?
Standard treatment for Neuropathic pain associated with diabetic peripheral neuropathy includes Lyrica. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Neuropathic pain associated with diabetic peripheral neuropathy?
FDA label publishes guidelines for Neuropathic pain associated with diabetic peripheral neuropathy. 4 guideline references tracked.
Related
- Treatment landscape: Neuropathic pain associated with diabetic peripheral neuropathy patent cliff · Neuropathic pain associated with diabetic peripheral neuropathy CI report
- Treatment: Lyrica · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing